These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 36941602)
1. Identification of the MMP family as therapeutic targets and prognostic biomarkers in the microenvironment of head and neck squamous cell carcinoma. Liu M; Huang L; Liu Y; Yang S; Rao Y; Chen X; Nie M; Liu X J Transl Med; 2023 Mar; 21(1):208. PubMed ID: 36941602 [TBL] [Abstract][Full Text] [Related]
2. Landscape Analysis of Matrix Metalloproteinases Unveils Key Prognostic Markers for Patients With Breast Cancer. Cheng T; Chen P; Chen J; Deng Y; Huang C Front Genet; 2021; 12():809600. PubMed ID: 35069702 [TBL] [Abstract][Full Text] [Related]
3. Identifying and validating MMP family members (MMP2, MMP9, MMP12, and MMP16) as therapeutic targets and biomarkers in kidney renal clear cell carcinoma (KIRC). Li K; Li D; Hafez B; Bekhit MMS; Jardan YAB; Alanazi FK; Taha EI; Auda SH; Ramzan F; Jamil M Oncol Res; 2024; 32(4):737-752. PubMed ID: 38560573 [TBL] [Abstract][Full Text] [Related]
4. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma. Sun K; Chen RX; Li JZ; Luo ZX Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179 [TBL] [Abstract][Full Text] [Related]
5. The matrix metalloproteinase gene family: a significant prognostic gene lineage correlated with immune infiltrates in laryngeal squamous cell carcinoma. Yang C; Cao H; Yang JW; Liu T; Wang JT; Wang BS Neoplasma; 2021 Nov; 68(6):1212-1224. PubMed ID: 34585589 [TBL] [Abstract][Full Text] [Related]
6. CCR5 as a prognostic biomarker correlated with immune infiltrates in head and neck squamous cell carcinoma by bioinformatic study. Li C; Chen S; Liu C; Mo C; Gong W; Hu J; He M; Xie L; Hou X; Tang J; Ou M Hereditas; 2022 Sep; 159(1):37. PubMed ID: 36167571 [TBL] [Abstract][Full Text] [Related]
7. MMP1 and MMP9 are potential prognostic biomarkers and targets for uveal melanoma. Wang T; Zhang Y; Bai J; Xue Y; Peng Q BMC Cancer; 2021 Sep; 21(1):1068. PubMed ID: 34587931 [TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase 1 is a poor prognostic biomarker for patients with hepatocellular carcinoma. Xu L; Yang H; Yan M; Li W Clin Exp Med; 2023 Oct; 23(6):2065-2083. PubMed ID: 36169759 [TBL] [Abstract][Full Text] [Related]
9. A pan-cancer perspective of matrix metalloproteases (MMP) gene expression profile and their diagnostic/prognostic potential. Gobin E; Bagwell K; Wagner J; Mysona D; Sandirasegarane S; Smith N; Bai S; Sharma A; Schleifer R; She JX BMC Cancer; 2019 Jun; 19(1):581. PubMed ID: 31200666 [TBL] [Abstract][Full Text] [Related]
10. Expression and prognostic analysis of BGN in head and neck squamous cell carcinoma. Zhao L; Liang J; Zhong W; Han C; Liu D; Chen X Gene; 2022 Jun; 827():146461. PubMed ID: 35358652 [TBL] [Abstract][Full Text] [Related]
11. Identification of novel therapeutic target and prognostic biomarker in matrix metalloproteinase gene family in pancreatic cancer. Luan H; Jian L; Huang Y; Guo Y; Zhou L Sci Rep; 2023 Oct; 13(1):17211. PubMed ID: 37821678 [TBL] [Abstract][Full Text] [Related]
12. NT5E upregulation in head and neck squamous cell carcinoma: A novel biomarker on cancer-associated fibroblasts for predicting immunosuppressive tumor microenvironment. Chen XM; Liu YY; Tao BY; Xue XM; Zhang XX; Wang LL; Zhong H; Zhang J; Yang SM; Jiang QQ Front Immunol; 2022; 13():975847. PubMed ID: 36091055 [TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of matrix metalloproteinases and their inhibitors in head and neck squamous cell carcinoma. Zou M; Zhang C; Sun Y; Wu H; Xiao F; Gao W; Zhao F; Fan X; Wu G Acta Oncol; 2022 Apr; 61(4):505-515. PubMed ID: 34879791 [No Abstract] [Full Text] [Related]
14. NUTF2 as a Prognostic Indicator and Potential Therapeutic Target in Head and Neck Squamous Cell Carcinoma. Li P; Wen X; Zhang X; Wang F; Zhang D; Shang H Genet Test Mol Biomarkers; 2022 Dec; 26(12):553-563. PubMed ID: 36577127 [No Abstract] [Full Text] [Related]
15. Interferon Regulatory Factor Family Genes: At the Crossroads between Immunity and Head and Neck Squamous Carcinoma. Liu S; Wang Z Dis Markers; 2022; 2022():2561673. PubMed ID: 35664436 [TBL] [Abstract][Full Text] [Related]
16. FOXD1 is a prognostic biomarker and correlated with macrophages infiltration in head and neck squamous cell carcinoma. Liang H; Zhang C; Li C; Li C; Wang Y; Lin H Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34028536 [TBL] [Abstract][Full Text] [Related]
17. Bioinformatics analysis of the role of CXC ligands in the microenvironment of head and neck tumor. Jing F; Wang J; Zhou L; Ning Y; Xu S; Zhu Y Aging (Albany NY); 2021 Jul; 13(13):17789-17817. PubMed ID: 34247149 [TBL] [Abstract][Full Text] [Related]
18. TPPP3 Associated with Prognosis and Immune Infiltrates in Head and Neck Squamous Carcinoma. Yang Z; Li X; Li J; Su Q; Qiu Y; Zhang Z; Zhang L; Mo W Biomed Res Int; 2020; 2020():3962146. PubMed ID: 33083464 [TBL] [Abstract][Full Text] [Related]
19. Comprehensive Analysis of the Expression and Prognosis for MMPs in Human Colorectal Cancer. Yu J; He Z; He X; Luo Z; Lian L; Wu B; Lan P; Chen H Front Oncol; 2021; 11():771099. PubMed ID: 34804973 [TBL] [Abstract][Full Text] [Related]
20. Up-regulation of extracellular-matrix and inflammation related genes in oral squamous cell carcinoma. Thakore VP; Patel KD; Vora HH; Patel PS; Jain NK Arch Oral Biol; 2024 May; 161():105925. PubMed ID: 38442470 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]